Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Explore gene therapy-based alternatives to electronic pacemakers in this research conference presented by Dr. Hee Cheol Cho, Director of the Blalock-Taussig-Thomas Pediatric and Congenital Heart Center at Johns Hopkins Children's Center. The 69-minute seminar from the University of Ottawa Heart Institute focuses on innovative approaches to treating bradyarrhythmia through somatic reprogramming to generate biological pacemaker cells, potentially offering solutions with fewer complications than conventional electronic devices. Dr. Cho, who also serves as Associate Professor across multiple departments at Johns Hopkins University School of Medicine, shares cutting-edge research on how gene therapy could revolutionize cardiac pacing technology.